Policy Brief: Evaluating the Value of a Real-world HTA agency (EVORA)
As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about innovative new health interventions, and/or support pricing negotiations. In this brief, we provide new evidence about the value a HTA agency provides, and suggestions for policy makers about how that value can be measured and enhanced.
Click here to view the policy brief.
Recommended
11 Sep 2023
14 Jul 2023
26 Jun 2023